Hanhee Cho
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Peptidase Inhibition and Analysis
Papers in
-
- Nanoparticle-Based Drug Delivery 9
- Oncology 12
- Cancer Immunotherapy and Biomarkers 5
- Peptidase Inhibition and Analysis 4
- Co-authors
- Kwangmeyung Kim (29 shared papers)Man Kyu Shim (13 shared papers)Jinseong Kim (16 shared papers)Yujeong Moon (14 shared papers)Suah Yang (7 shared papers)Seong Ik Jeon (9 shared papers)Hong Yeol Yoon (7 shared papers)Wan Su Yun (8 shared papers)
- Journals
- Pharmaceutics (5 papers)Biomaterials (3 papers)Theranostics (2 papers)Molecules (2 papers)ACS Nano (2 papers)
- Partner nations
- South KoreaUnited StatesEthiopia
In The Last Decade
Hanhee Cho
29 papers receiving 968 citations
Peers
Comparison fields: 5 of 72
- Biomaterials 305
- Oncology 248
- Immunology 182
- Biomedical Engineering 397
- Pharmaceutical Science 38
Countries citing papers authored by Hanhee Cho
This map shows the geographic impact of Hanhee Cho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanhee Cho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanhee Cho more than expected).
Fields of papers citing papers by Hanhee Cho
This network shows the impact of papers produced by Hanhee Cho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanhee Cho. The network helps show where Hanhee Cho may publish in the future.
Co-authors
The 25 scholars most cited alongside Hanhee Cho, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 146 | |
| 2 | 2022 | 109 | |
| 3 | 2022 | 104 | |
| 4 | 2020 | 91 | |
| 5 | 2023 | 75 | |
| 6 | 2024 | 63 | |
| 7 | 2023 | 58 | |
| 8 | 2022 | 53 | |
| 9 | 2023 | 42 | |
| 10 | 2019 | 28 | |
| 11 | 2024 | 28 | |
| 12 | 2022 | 27 | |
| 13 | 2021 | 24 | |
| 14 | 2024 | 21 | |
| 15 | 2023 | 19 | |
| 16 | 2024 | 19 | |
| 17 | 2023 | 17 | |
| 18 | 2022 | 14 | |
| 19 | 2023 | 13 | |
| 20 | 2024 | 10 |
About Hanhee Cho
Hanhee Cho is a scholar working on Biomaterials, Oncology, Immunology, Biomedical Engineering and Hematology, having authored 33 papers that have together received 997 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (14 papers), Nanoparticle-Based Drug Delivery (9 papers), Immunotherapy and Immune Responses (8 papers), Protein Degradation and Inhibitors (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Peptidase Inhibition and Analysis (4 papers), Multiple Myeloma Research and Treatments (4 papers) and Photodynamic Therapy Research Studies (3 papers). The work is most often cited by research in Biomaterials (305 citations), Oncology (248 citations), Immunology (182 citations), Biomedical Engineering (397 citations) and Pharmaceutical Science (38 citations). Hanhee Cho has collaborated with scholars based in South Korea, United States and Ethiopia. Frequent co-authors include Kwangmeyung Kim, Man Kyu Shim, Jinseong Kim, Yujeong Moon, Suah Yang, Seong Ik Jeon, Hong Yeol Yoon, Wan Su Yun, Cheol‐Hee Ahn and Jiwoong Choi. Their work appears in journals such as Pharmaceutics, Biomaterials, Theranostics, Molecules and ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.